Document Detail


Differences in the evolution of imipenem susceptibility among Klebsiella pneumoniae and Escherichia coli isolates during a 6-year period in a tertiary care hospital.
MedLine Citation:
PMID:  17207610     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The evolution of imipenem disk-diffusion susceptibility results of 2652 strains of Klebsiella pneumoniae and 7596 Escherichia coli isolated during the period 2000-2005 were analysed. Screening for production of metallo-beta-lactamases was performed using the EDTA-synergy method. The percentage rate of K. pneumoniae isolates having a zone diameter < or =25 mm increased from 20% in 2000 to 41% in 2005, whereas the respective rate of isolates having a zone diameter > or =30 mm decreased from 48 to 23%. These changes were more evident during 2000-2002, followed in 2003 by the isolation of the first imipenem-resistant strains. Regarding E. coli, a similar decrease was observed (the rates of isolates having a zone diameter < or =25 mm and > or =30 mm changed from 7% and 68% in 2000, to 32% and 36% in 2005, respectively) following the respective changes of K. pneumoniae. A total of 20 K. pneumoniae strains, but no E. coli, were confirmed as metallo-beta-lactamase producers. In conclusion, a decrease of the imipenem susceptibility prior to the isolation of the first resistant strains in a tertiary care hospital was detected, as well as differences in this decrease between the two species. These findings indicate that monitoring of the evolution of imipenem susceptibility in real-time may help in unveiling forthcoming resistance and in implementing the appropriate diagnostic techniques.
Authors:
Joseph Papaparaskevas; Angeliki Pantazatou; Ioanna Stefanou; Victoria Mela; Nikolaos Galatidis; Athina Avlamis
Publication Detail:
Type:  Journal Article     Date:  2007-01-04
Journal Detail:
Title:  International journal of antimicrobial agents     Volume:  29     ISSN:  0924-8579     ISO Abbreviation:  Int. J. Antimicrob. Agents     Publication Date:  2007 Feb 
Date Detail:
Created Date:  2007-01-15     Completed Date:  2007-03-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9111860     Medline TA:  Int J Antimicrob Agents     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  197-200     Citation Subset:  IM    
Affiliation:
Department of Microbiology, Laikon General Hospital, 11527 Athens, Greece. ipapapar@med.uoa.gr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Bacterial Agents / pharmacology*
Edetic Acid / pharmacology
Escherichia coli / drug effects*
Humans
Imipenem / pharmacology*
Klebsiella pneumoniae / drug effects*
Microbial Sensitivity Tests
beta-Lactamases / biosynthesis
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 60-00-4/Edetic Acid; 74431-23-5/Imipenem; EC 3.5.2.6/beta-Lactamases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Caspofungin for the treatment of fungal infections: a systematic review of randomized controlled tri...
Next Document:  Further investigation of the mechanism of Doxorubicin release from P105 micelles using kinetic model...